NanoViricides
NNVC
#10068
Rank
โ‚ฌ22.94 M
Marketcap
1,06ย โ‚ฌ
Share price
-3.10%
Change (1 day)
-24.39%
Change (1 year)

NanoViricides (NNVC) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ1 Million

According to NanoViricides's latest financial reports the company's total liabilities are โ‚ฌ1 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NanoViricides - Total liabilities on balance sheet (from 2006 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-06-30โ‚ฌ1.26 M-32.09%
2023-06-30โ‚ฌ1.86 M373.01%
2022-06-30โ‚ฌ0.39 M33.04%
2021-06-30โ‚ฌ0.29 M-84.57%
2020-06-30โ‚ฌ1.91 M-23.42%
2019-06-30โ‚ฌ2.5 M232.56%
2018-06-30โ‚ฌ0.75 M-87.13%
2017-06-30โ‚ฌ5.85 M-52.14%
2016-06-30โ‚ฌ12.23 M9.83%
2015-06-30โ‚ฌ11.13 M-25.57%
2014-06-30โ‚ฌ14.96 M131.89%
2013-06-30โ‚ฌ6.45 M358.99%
2012-06-30โ‚ฌ1.4 M247.11%
2011-06-30โ‚ฌ0.4 M-79.52%
2010-06-30โ‚ฌ1.97 M442.29%
2009-06-30โ‚ฌ0.36 M-43.94%
2008-06-30โ‚ฌ0.65 M2.89%
2007-06-30โ‚ฌ0.63 M-46.29%
2006-06-30โ‚ฌ1.17 M2028.85%
2005-06-30โ‚ฌ0.05 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
BioCryst Pharmaceuticals
BCRX
โ‚ฌ0.71 B 70,461.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚ฌ1.13 B 112,938.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ31.55 B 3,135,667.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ66.63 B 6,621,150.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ66.08 B 6,566,176.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ52.16 B 5,182,995.26%๐Ÿ‡ฌ๐Ÿ‡ง UK